Shawn J. Silengo

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

Jorge E. Osorio, Iván Darío Vélez, Cynthia A. Thomson et al. · The Lancet Infectious Diseases · 2014 · 149 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +9

Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques

Jorge E. Osorio, Joseph N. Brewoo, Shawn J. Silengo et al. · American Journal of Tropical Medicine and Hygiene · 2011 · 111 citations · Full text

The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion

Claire Y.‐H. Huang, Siritorn Butrapet, Kelly J. Moss et al. · Virology · 2009 · 80 citations

Membrane Fusion, Virus Structure, Immunology +6

Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes

Juliet E. Bryant, Amanda E. Calvert, Kyeen Mesesan et al. · Virology · 2007 · 73 citations

Virus Growth, Pathogenesis, Glycobiology +7

Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice

Joseph N. Brewoo, Richard M. Kinney, Tim D. Powell et al. · Vaccine · 2011 · 70 citations · Full text

Vaccination, Vaccine Development, Interferon-deficient Ag129 Mice +7